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Mellitus: Are We on the Wrong Track?Wehave readwith great interest the recently published
article by Jensen et al. (1) about the 2-dimensional
mechanics in a large cohort of patients with type 1
diabetes mellitus (T1DM). The investigators reported
signiﬁcant difference in left ventricular (LV) global
longitudinal strain (GLS) between the control subjects
and the T1DM subjects with albuminuria, whereas the
diabetic patients and those with normoalbuminuria
have similar GLS as the healthy control subjects do,
even though these patients have had T1DM without
tight glycemic control (glycosylated hemoglobin
>8%) for more than 2 decades.
We would like to discuss several important points
of this investigation. The absolute value of GLS in the
control group is somewhat lower than expected for
the healthy mid-age population. Interestingly, dia-
stolic blood pressure and LV mass index are higher in
the control group than in the T1DM patients, espe-
cially than in the T1DM subjects with normoalbumi-
nuria, probably due to medical therapy.
The other important issue is the lack of association
between the usage of various medications and LV
mechanical remodeling in T1DM. The investigators
found that the treatment of statins, beta-blockers,
calcium-channel blockers, angiotensin-converting
enzymes, and angiotensin II inhibitors or diuretics is
not associated with any improvement of GLS in the
diabetic population. The data on this topic are scarce
and inconsistent, and this kind of investigation with a
large population of uncomplicated diabetic patients
has been waiting for a long time. The previous in-
vestigations showed that all these drugs improve LV
structure (reducing LVmass) and systolic and diastolic
function. Is it possible that they are completely inef-
fective for improvement of LV longitudinal function?Previously it was shown that statins improve LV
longitudinal function and that was evaluated using
different imaging techniques than speckle tracking
(2). Mizuguchi et al. (3) reported that telmisartan
signiﬁcantly improved GLS in hypertensive patients,
but only after 12 months. This ﬁnding raises
the question about the duration of therapy in the
present study, which was not been presented. Perhaps
longer duration of therapy would change the
results. Furthermore, Motoki et al. (4) recently showed
that calcium-channel blockers also have favorable
inﬂuence on GLS, even after only 3 months of therapy.
Beta-1 blockade, induced by bisoprolol, results in the
reduction of GLS (5). However, the percentage of the
T1DM patients who used beta-blockers in the present
study is not high enough to change the ﬁnal result,
especially in the subjects with normoalbuminuria.
Jensen et al. (1) showed that the usage of any of the
medications was not independently associated with
GLS. However, the present multivariate model consists
of some variables that interact (systolic and diastolic
blood pressure, body mass index and LV mass index).
It would be helpful to perform a multivariate analysis
considering the inﬂuence of the variables from model
3 on LV mass index and E/e0 in order to evaluate the
effect of different medications on LV structure and
diastolic function in this population.
The Thousand & 1 Study raises many questions that
need to be resolved and conﬁrmed, but it certainly
represents a solid ground for further investigations.Marijana Tadic, MD, PhD*
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Echocardiogr 2009;10:745–52.REPLY: Longitudinal Strain and Type 1
Diabetes Mellitus: Are We on the
Wrong Track?We thank Drs. Tadic and Cuspidi for their interest in
our paper (1). Drs. Tadic and Cuspidi comment that
global longitudinal strain (GLS) in the present study
is somewhat lower than expected for a healthy
middle-aged population; for example, like in the
reports of Kocabay et al. (2) and Yingchocharoen et
al. (3). First, the reason for including a control
population in the present study is precisely to
compare results with a healthy, normal population,
rather than with estimates from the published
reports, knowing that absolute GLS values differ
between reports. Second, the Kocabay et al. (2) study
included 247 subjects, and the meta-analysis from
Yingchocharoen et al. (3) reported GLS estimates
compiled from 28 different studies with a total of
2,597 individuals; in that study, individual study
populations ranged from 13 individuals to 673
individuals. In comparison, the present population of
1,263 individuals (1,065 patients with type 1 diabetes
mellitus [T1DM] and 198 control subjects) is almost
one-half the size of the total participant number in
the meta-analysis where reported mean GLS values
were between –15.9% and –22.1%. We report that the
control subjects have a mean GLS of –18.8% and
T1DM patients a GLS of –18.3%, which we ﬁnd to be
reasonable and within expected limits.Also, Drs. Tadic and Cuspidi discuss whether or
not medical therapy in T1DM can improve left ven-
tricular structure and function, and they reference a
series of randomized controlled trials on this sub-
ject. The present cross-sectional study was not
designed to address this matter, but we would sus-
pect that cardiac function would be worse in pa-
tients from the Thousand & 1 Study had they not
received cardioprotective and renoprotective medi-
cations via their usual clinical control at the outpa-
tient clinic at Steno Diabetes Center. Drs. Tadic and
Cuspidi further suggest investigating the association
between medication and LV structure and function
in T1DM more closely. We are thankful for this
suggestion and look forward to doing this in future
studies.Magnus Thorsten Jensen, MD, PhD*
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